Literature DB >> 15749636

Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon.

Daniel M Commane1, Colette T Shortt, Stefania Silvi, Albert Cresci, Roisin M Hughes, Ian R Rowland.   

Abstract

Evidence from in vivo and in vitro studies suggests that the consumption of pro- and prebiotics may inhibit colon carcinogenesis; however, the mechanisms involved have, thus far, proved elusive. There are some indications from animal studies that the effects are being exerted during the promotion stage of carcinogenesis. One feature of the promotion stage of colorectal cancer is the disruption of tight junctions, leading to a loss of integrity across the intestinal barrier. We have used the Caco-2 human adenocarcinoma cell line as a model for the intestinal epithelia. Trans-epithelial electrical resistance measurements indicate Caco-2 monolayer integrity, and we recorded changes to this integrity following exposure to the fermentation products of selected probiotics and prebiotics, in the form of nondigestible oligosaccharides (NDOs). Our results indicate that NDOs themselves exert varying, but generally minor, effects upon the strength of the tight junctions, whereas the fermentation products of probiotics and NDOs tend to raise tight junction integrity above that of the controls. This effect was bacterial species and oligosaccharide specific. Bifidobacterium Bb 12 was particularly effective, as were the fermentation products of Raftiline and Raftilose. We further investigated the ability of Raftilose fermentations to protect against the negative effects of deoxycholic acid (DCA) upon tight junction integrity. We found protection to be species dependent and dependent upon the presence of the fermentation products in the media at the same time as or after exposure to the DCA. Results suggest that the Raftilose fermentation products may prevent disruption of the intestinal epithelial barrier function during damage by tumor promoters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749636     DOI: 10.1207/s15327914nc5101_14

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  21 in total

Review 1.  Probiotics and gut health: a special focus on liver diseases.

Authors:  Silvia Wilson Gratz; Hannu Mykkanen; Hani S El-Nezami
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

2.  Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis.

Authors:  Saman Khalesi; David Wayne Johnson; Katrin Campbell; Susan Williams; Andrew Fenning; Sonia Saluja; Christopher Irwin
Journal:  Eur J Nutr       Date:  2017-11-08       Impact factor: 5.614

3.  CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.

Authors:  Rebecca A Vongsa; Noah P Zimmerman; Michael B Dwinell
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

4.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

5.  Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial.

Authors:  A Gori; G Rizzardini; B Van't Land; K B Amor; J van Schaik; C Torti; T Quirino; C Tincati; A Bandera; J Knol; K Benlhassan-Chahour; D Trabattoni; D Bray; A Vriesema; G Welling; J Garssen; M Clerici
Journal:  Mucosal Immunol       Date:  2011-04-27       Impact factor: 7.313

Review 6.  Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.

Authors:  Nathalie M Delzenne; Audrey M Neyrinck; Patrice D Cani
Journal:  Microb Cell Fact       Date:  2011-08-30       Impact factor: 5.328

7.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

Review 8.  Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function.

Authors:  Elizabeth C Rose; Jack Odle; Anthony T Blikslager; Amanda L Ziegler
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 6.208

9.  Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats.

Authors:  Anna Lyra; Markku Saarinen; Heli Putaala; Kaisa Olli; Sampo J Lahtinen; Arthur C Ouwehand; Mari Madetoja; Kirsti Tiihonen
Journal:  Gastroenterol Res Pract       Date:  2012-07-17       Impact factor: 2.260

Review 10.  Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Authors:  Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.